OpenLB
Open Library of Bioscience
Advanced Search
Pharmaceuticals (Basel, Switzerland)
Sep 06, 2023;16 (9):

Special Issue "Drug Candidates for the Treatment of Infectious Diseases".

Chung Man Chin, Jean Leandro Dos Santos
Author Information
  1. Chung Man Chin: School of Pharmaceutical Science, State University of São Paulo (Unesp), Araraquara 14800-903, Brazil. ORCID
  2. Jean Leandro Dos Santos: School of Pharmaceutical Science, State University of São Paulo (Unesp), Araraquara 14800-903, Brazil. ORCID
PMID: 37765065 DOI: 10.3390/ph16091257

Abstract

Infectious diseases encompass a range of conditions stemming from parasites [...].

References

  1. Pharmaceuticals (Basel). 2022 Jan 27;15(2): [PMID: 35215268]
  2. PLoS Med. 2018 Jul 3;15(7):e1002595 [PMID: 29969463]
  3. Adv Drug Deliv Rev. 2021 Aug;175:113818 [PMID: 34090965]
  4. Biotechnol Adv. 2022 Jul-Aug;57:107937 [PMID: 35271946]
  5. Pharmaceuticals (Basel). 2022 Apr 22;15(5): [PMID: 35631339]
  6. Pharmaceuticals (Basel). 2022 May 21;15(5): [PMID: 35631461]
  7. Pharmaceuticals (Basel). 2022 Jan 18;15(2): [PMID: 35215223]
  8. J Ind Microbiol Biotechnol. 2016 Mar;43(2-3):155-76 [PMID: 26739136]
  9. Nature. 2018 Jul;559(7715):498-506 [PMID: 30046073]
  10. Postepy Biochem. 2016;62(3):262-272 [PMID: 28132480]
  11. J Med Chem. 2013 Oct 24;56(20):7719-26 [PMID: 24015767]
  12. Nat Rev Drug Discov. 2021 Mar;20(3):200-216 [PMID: 33510482]
  13. Pharmaceuticals (Basel). 2022 Jun 22;15(7): [PMID: 35890072]
  14. Pharmaceuticals (Basel). 2022 Jun 30;15(7): [PMID: 35890113]
  15. Pharmaceuticals (Basel). 2022 Feb 03;15(2): [PMID: 35215308]
  16. Nat Rev Microbiol. 2022 Apr;20(4):193-205 [PMID: 34646006]
  17. Protein Pept Lett. 2020;27(1):4-16 [PMID: 31438824]
  18. Cell. 2020 Apr 2;181(1):29-45 [PMID: 32197064]
  19. Nat Rev Microbiol. 2023 May;21(5):280-295 [PMID: 36411397]
  20. Biomolecules. 2023 Jun 14;13(6): [PMID: 37371566]
  21. Pharmaceuticals (Basel). 2022 Jun 29;15(7): [PMID: 35890108]
  22. Pharmaceuticals (Basel). 2022 Mar 24;15(4): [PMID: 35455392]
  23. Curr Opin Virol. 2012 Oct;2(5):614-21 [PMID: 23057872]
  24. Pharmaceuticals (Basel). 2021 Dec 15;14(12): [PMID: 34959707]
  25. Pharmaceuticals (Basel). 2022 May 27;15(6): [PMID: 35745589]
  26. J Med Chem. 2013 Oct 24;56(20):7727-40 [PMID: 23927763]
  27. Pharmaceuticals (Basel). 2022 May 15;15(5): [PMID: 35631435]
  28. Curr Opin Microbiol. 2019 Oct;51:72-80 [PMID: 31733401]
  29. Pharmaceuticals (Basel). 2022 Jul 01;15(7): [PMID: 35890119]
  30. Pharmaceuticals (Basel). 2022 Feb 21;15(2): [PMID: 35215369]
  31. Pharmaceuticals (Basel). 2022 Jul 21;15(7): [PMID: 35890202]
  32. Pharmaceuticals (Basel). 2022 Feb 15;15(2): [PMID: 35215340]
  33. EMBO Rep. 2020 Dec 3;21(12):e51034 [PMID: 33400359]
  34. Int J Mol Sci. 2021 Dec 09;22(24): [PMID: 34948055]
  35. Pharmaceuticals (Basel). 2022 Sep 13;15(9): [PMID: 36145362]
  36. Pharmaceuticals (Basel). 2022 Apr 20;15(5): [PMID: 35631327]
  37. Drug Discov Today. 2020 Oct;25(10):1807-1821 [PMID: 32801051]
  38. Nat Chem. 2018 Apr;10(4):383-394 [PMID: 29568051]
  39. Pharmaceuticals (Basel). 2021 Oct 01;14(10): [PMID: 34681237]
  40. Pharmaceuticals (Basel). 2022 Jun 03;15(6): [PMID: 35745631]

Grants

  1. Finance Code 001/Coordenação de Aperfeicoamento de Pessoal de Nível Superior
  2. 2018/11079-0/São Paulo Research Foundation
Editorial

Word Cloud

Created with Highcharts 10.0.0Infectiousdiseasesencompassrangeconditionsstemmingparasites[]SpecialIssue"DrugCandidatesTreatmentDiseases"

Similar Articles

Cited By